BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1714561)

  • 1. Tumor angiogenesis.
    Tobelem G
    Nouv Rev Fr Hematol (1978); 1990; 32(6):405-6. PubMed ID: 1714561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial cell growth: biology and pharmacology in relation to angiogenesis.
    Tobelem G
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):703-5. PubMed ID: 1723309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Angiogenic factors].
    Camez A; Tobelem G
    Nouv Rev Fr Hematol (1978); 1987; 29(1):57-9. PubMed ID: 2438646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis: an update.
    Díaz-Flores L; Gutiérrez R; Varela H
    Histol Histopathol; 1994 Oct; 9(4):807-43. PubMed ID: 7534514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Angiogenesis and its regulation].
    Iwaguchi T
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):1-9. PubMed ID: 7678486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.
    Rofstad EK; Halsør EF
    Cancer Res; 2000 Sep; 60(17):4932-8. PubMed ID: 10987309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Angiogenesis, lymphangiogenesis, and tumor progression].
    Hawighorst T
    Zentralbl Gynakol; 2002 Nov; 124(11):497-505. PubMed ID: 12796842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparins and angiogenesis.
    Norrby K
    APMIS; 2006 Feb; 114(2):79-102. PubMed ID: 16519745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the biology of angiogenesis: review of the most important molecular mechanisms.
    Otrock ZK; Mahfouz RA; Makarem JA; Shamseddine AI
    Blood Cells Mol Dis; 2007; 39(2):212-20. PubMed ID: 17553709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
    Pradeep CR; Sunila ES; Kuttan G
    Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biology of angiogenesis in tumors of the gastrointestinal tract.
    Reinmuth N; Parikh AA; Ahmad SA; Liu W; Stoeltzing O; Fan F; Takeda A; Akagi M; Ellis LM
    Microsc Res Tech; 2003 Feb; 60(2):199-207. PubMed ID: 12539174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cells and angiogenesis.
    Hiromatsu Y; Toda S
    Microsc Res Tech; 2003 Jan; 60(1):64-9. PubMed ID: 12500262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor angiogenesis].
    Lukesová S; Kopecký O; Dvorák J; Hlávková D; Vroblová V
    Vnitr Lek; 2006 Sep; 52(9):797-800. PubMed ID: 17091603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-angiogenic function of tocotrienol.
    Miyazawa T; Shibata A; Nakagawa K; Tsuzuki T
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():253-6. PubMed ID: 18296349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis--a new target for future therapy.
    Pandya NM; Dhalla NS; Santani DD
    Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet factor 4: an inhibitor of angiogenesis.
    Bikfalvi A
    Semin Thromb Hemost; 2004 Jun; 30(3):379-85. PubMed ID: 15282661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vasculogenesis and angiogenesis: molecular and cellular controls. II. The interactions between the cell and its environment].
    Kubis N; Levy BI
    Morphologie; 2003 Mar; 87(276):31-6. PubMed ID: 12793112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth.
    Hamano Y; Kalluri R
    Biochem Biophys Res Commun; 2005 Jul; 333(2):292-8. PubMed ID: 15979458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
    Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T
    Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
    Wong ML; Prawira A; Kaye AH; Hovens CM
    J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.